Ada Health, developer of an AI-powered symptom assessment and care-navigation platform, expanded its leadership team as the company hit profitability and reported a 260% rise in revenue year over year.
Nick Altebrando is the company's new chief product officer, and Yury Rozenman will be senior vice president of business development.
Ada's AI-powered symptom checker is built on 13 years of...
A $30 million (€26 million) extension has helped Ada Health to close its latest series B round at $120 million (€105 million).
Among the new investors from Europe and the US are Farallon Capital, Red River West, Bertelsman Investments and Schroders Capital, the latter with an acquisition of vehicles. With the funding provided, Ada Health plans to expand into the US healthcare market.
“Today’s...
The partnership will help visitors to Bayer websites for Aspirin, Aleve, Midol, Cenesten and Iberogast to access Ada’s intelligent symptom assessment platform.
Using an AI-based health assessment platform, Berlin-based Ada Health assists users in identifying the correct care, based on their individual requirements, risk factors and symptoms.
The free app provides guidance via an AI chatbot which...
Berlin-based global health company Ada has signed more than 10 new partnerships with key players across sciences, insurance and health systems, including AXA OneHealth, Santéclair, Novartis, CUF, TAJ Digital Health and Sutter Health.
These organisations have opted for this partnership in order to improve patient experiences, leveraging Ada’s enterprise solutions to support the delivery of...
Berlin-based digital health company Ada Health has announced a $90 million (€74m) Series B funding investment led by Leaps by Bayer, the impact investment arm of Bayer AG, which will support the company with its expertise in scientific innovation and consumer healthcare.
Other investors in the round include Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures.
This...
Berlin-based medical AI company Ada Health has announced the launch of a new partnership with Novartis in order to speed up the diagnosis for patients with immunological diseases and rare conditions.
The partnership will see Novartis use Ada Health’s AI-based, clinically validated, symptom assessment and care navigation solutions to help improve the identification and diagnosis of a number of...
Paarl-based digital healthcare company, Udok, has raised R10 million (€518k) from local venture capital firm, FinX Capital, to expand their offering across the country.
Udok runs a Connected Care Platform using proprietary intellectual property developed in-house.
WHY IT MATTERS
Udok has been providing remote consultations directly to patients and via pharmacy clinics for the past year and has...
Paul Wicks is a scientific advisor for digital health company Ada Health. At Ada, Paul works on strategy, rare diseases and scientific communications. A rare diseases expert, Paul is a neuropsychologist and independent consultant for digital health, clinical trials, and patient centricity. Previously, he spent 13 years leading the R&D team at PatientsLikeMe, an online community for over 700,...
As pressures on healthcare systems intensify, an increasing number of consumers are turning to the use of symptom checkers in the search for fast answers – or guidance – to any concerns that they may have. But although these tools have become popular, questions around their accuracy, and not only, are plaguing the digital health space.
Last week, at Slush, Ada Health cofounder and chief medical...
Ada Health is expanding its services in East Africa with a new Swahili language version of its artificial intelligence assessment app.
The tool is pitched as a way for clinicians and patients to get more information about potential symptom causes as well as localized action steps about what to do next.
“The Swahili version of the Ada app can be accessed via smartphone, and offers support to...
